Keyphrases
Advanced Melanoma
25%
Agent Strategies
25%
Antitumor Immune Response
25%
Cancer Immunotherapy
100%
Cancer Patients
25%
Cancer Types
25%
Cancer Vaccine
25%
Clinical Development
25%
Clinical Evaluation
25%
Counterregulation
25%
Cytotoxic T-lymphocyte antigen-4 (CTLA-4)
25%
Effector Mechanisms
25%
Hijacking
25%
Immune Attack
25%
Immune Effectors
25%
Immunotherapeutics
25%
In Cancer
25%
Ipilimumab
25%
Patient Outcomes
25%
Prostate Cancer
25%
Provenge
25%
Recurring
25%
Sipuleucel-T
25%
Therapeutic Maneuvers
25%
Therapeutic Modalities
25%
Therapeutic Outcome
25%
Treatment Strategy
25%
Tumor Cells
50%
Tumor Escape
100%
Immunology and Microbiology
Cancer Immunotherapy
100%
Cancer Vaccine
25%
CTLA-4
25%
Immune Response
25%
Immunomodulating Drugs
25%
Immunotherapy
25%
Ipilimumab
25%
Prostate
25%
Sipuleucel-T
50%
Tumor Cell
50%
Tumor Escape
100%
Pharmacology, Toxicology and Pharmaceutical Science